Masayuki Ikeda

6PUBLICATIONS
1CO-AUTHORS
PharmacogenomicsPsychosocial aspects of childbirth and perinatal mental healthToxicology (incl. clinical toxicology)Cardiology (incl. cardiovascular diseases)Cheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 01, 2021
Potential adverse events in Japanese women who received tozinameran (BNT162b2, Pfizer-BioNTech).

Rumiko Shimazawa, Masayuki Ikeda

|Mar 11, 2021
Approvals of type 2 diabetes drugs tested in cardiovascular outcome trials: A tripartite comparison.

Rumiko Shimazawa, Masayuki Ikeda

|Dec 14, 2019
Imbalance in glycemic control between the treatment and placebo groups in cardiovascular outcome trials in type 2 diabetes.

Rumiko Shimazawa, Masayuki Ikeda

|Jul 18, 2019
Challenges to hemoglobin A1c as a therapeutic target for type 2 diabetes mellitus.

Masayuki Ikeda, Rumiko Shimazawa

|Nov 21, 2018
Natural language processing-based assessment of consistency in summaries of product characteristics of generic antimicrobials.

Rumiko Shimazawa, Yoshinobu Kano, Masayuki Ikeda

Pageof 1

Frequent Collaborators